Page 802 - Problem-Based Feline Medicine
P. 802

794   PART 9   CAT WITH SIGNS OF GASTROINTESTINAL TRACT DISEASE


          to decrease esophageal dilation and increase gastric  Relieve constipation using laxatives and enemas. See
          emptying, and hence reduce vomiting and regurgi-  page 785 (Constipation (including idiopathic mega-
          tation.                                       oesphagus)).
          ● Cisapride (Propulsid, 2.5–5 mg/cat q 8–12 h) is
                                                        Manual emptying of the bladder and colon may be
            thought to be more effective than metoclopramide,
                                                        required if drug therapy is ineffective. Urine should be
            and can be combined with metoclopramide to
                                                        monitored for bacterial infection, and infection treated
            improve gastric emptying and small intestinal
                                                        promptly.
            motility. Cisapride is indicated in cats with
            esophagitis from vomiting. Cisapride is currently
            unavailable in the USA. Nizatadine (2.5–5 mg/kg  Prognosis
            PO once daily) or ranitidine (1–2 mg/kg PO q
                                                        Initial severity of clinical signs is not necessarily corre-
            8–12 h) may be used instead as colonic prokinetic
                                                        lated with survival, and response to treatment is a bet-
            agents.
                                                        ter indication of prognosis.
          Dysuria, urinary bladder emptying, and gastrointestinal
                                                        The prognosis is guarded to poor, especially in cats
          motility may be improved with  bethanecol (2.5–5.0
                                                        with megaesophagus. If cats continue to regurgitate flu-
          mg PO q 8–12 h, or 0.0375 mg/kg SC q 8–12 h). Start
                                                        ids after 1–2 weeks of treatment, consider euthanasia.
          with the lower dose and increase if necessary, but
          beware of adverse effects such as bradycardia and  The mortality rate is approximately 60%, and surviving
          arrhythmias).                                 cats may have residual signs.
           RECOMMENDED READING

          Firth M, Fondacaro JV, Greco DS. Challenging cases in internal medicine: What’s your diagnosis? Vet Med 2000;
            95(8): 606–614.
          Grauer GF. Feline lower urinary tract inflammation. In: Nelson RW, Couto CG (eds) Small Animal Internal
            Medicine, 3rd edn. Missouri, Mosby, 2003, pp. 642–649.
          Washabau RJ, Hasler AH. Constipation, obstipation and megacolon. In: August JR (ed) Consultations in Feline
            Internal Medicine, 3rd edn. Philadelphia, PA, W.B. Saunders, 1997, pp. 104–112.
          White RN. Surgical management of constipation. J Feline Med Surg 2002; 4(3): 129–138.
   797   798   799   800   801   802   803   804   805   806   807